You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
3 November 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Tuesday that it has initiated ENHANCE-3, a Phase 3 clinical trial evaluating Ohtuvayre (ensifentrine) for preventing chron...
3 November 2026 - Swedish oncology-focused development company Vivesto AB (STO:VIVE) said on Tuesday that it has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for Cantrixil as a treatment for acute myeloid leuk...
3 November 2026 - Clinical-stage biotech company Lytix Biopharma ASA (Euronext Growth Oslo:LYTIX) announced on Tuesday that its Phase II NeoLIPA study evaluating ruxotemitide in combination with pembrolizumab in patients with resectable melanoma has ...
3 November 2026 - Swedish healthcare group Asker Healthcare Group AB (STO: ASKER), which provides medical products and solutions across Europe, said on Tuesday it has acquired 100% of the shares in Teresa OÜ, an Estonian supplier of mobility aid...
2 November 2026 - Healthcare company Roche (SIX: RO, ROP) (OTCQX: RHHBY) announced on Monday that it has received US Food and Drug Administration 510(k) clearance for its cobas eplex respiratory pathogen panel 3 (RP3), enabling laboratories to custom...
2 November 2026 - Healthcare company Abbott (NYSE: ABT) reported on Monday that it has achieved positive one-year results from the pivotal VERITAS study of its investigational Amulet 360 Left Atrial Appendage (LAA) Occluder, demonstrating high closur...
INOVIO's VOCERYQ receives US FDA accelerated approval to reduce surgery frequency in adults with RRP
2 November 2026 - INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercialising DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, announced on Friday that the US Food a...